Inflammation Assay
Discover our cutting-edge in vitro inflammation assay, developped to provide accurate and reliable results.
Tissue inflammation represents a pivotal pathological condition observed across a broad spectrum of both acute and chronic diseases.
Our inflammation assays offer a comprehensive platform for studying inflammatory responses in a controlled environment. From drug discovery to understanding disease mechanisms, our dosing technology allows to delve deeper into inflammation pathways, paving the way for breakthroughs in therapeutic development.
In addition to analyzing conventional pro-inflammatory cytokines using methods like LUMINEX or the Ella Automated Immunoassay System, our inflammation assay goes further by examining the cellular mechanisms behind inflammation through multi-parameter analyses, including gene expression studies and immunofluorescence.
- Inflammatory panels (IFN-γ, TNF-α, IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, CRP and more).
- Cytokine and Chemokine panels (MCP-1, MCP-4, Eotaxin, IP-10, GM-CSF, IL-15, IL-16, IL-17A, TSLP, TNF- β and more)
The assay can be customized to suit specific experimental requirements, allowing for the assessment of various cell types, treatments, and conditions.
Highly sensitive ELISA or Multiplex dosage of secreted cytokines by ELLA-multiplex
With multiplex capabilities, our assay enables simultaneous quantification of multiple cytokines, providing a comprehensive profile of the inflammatory response.
Example of Study design
Exemple of Assay readouts
Primary RPTEC cells response to 5 days in high glucose medium:
